Metraipolis › archive › dc_28aa121abf65

CircPPFIA2 drives prostate cancer progression and enzalutamide resistance by sponging miR-646 and miR-1200 to upregulate ETS1 — Europe PMC PMID:41360764

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41360764
DOI
10.1038/s41420-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-07T20:00:17.684Z
SHA-256 of the archived text
5aa4a3eb553efd5cd4223caa299ad8fe29fe9453c1f2ddce5de56eeb9fb8116f
Stable URL of this page
https://metraipolis.com/documento/dc_28aa121abf65

How to cite

CircPPFIA2 drives prostate cancer progression and enzalutamide resistance by sponging miR-646 and miR-1200 to upregulate ETS1 — Europe PMC PMID:41360764 — Europe PMC (en), https://europepmc.org/article/MED/41360764 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_28aa121abf65 (Metraipolis archive dc_28aa121abf65, sha256 5aa4a3eb553efd5cd4223caa299ad8fe29fe9453c1f2ddce5de56eeb9fb8116f)
BibTeX
@misc{dc28aa121abf65,
  title = {CircPPFIA2 drives prostate cancer progression and enzalutamide resistance by sponging miR-646 and miR-1200 to upregulate ETS1 — Europe PMC PMID:41360764},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41360764},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_28aa121abf65; sha256 5aa4a3eb553efd5cd4223caa299ad8fe29fe9453c1f2ddce5de56eeb9fb8116f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41360764. Agents can read the archived copy with the MCP tool read_document.